Rare Insights

Exploring the ideas, innovations, and individuals shaping the future of rare disease.

EU Joint Clinical Assessment: What Sponsors Need to Know in 2025

The Joint Clinical Assessment (JCA) came into force in January 2025. It begins with oncology and advanced therapies and[…]

We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept